Published online Nov 24, 2026. doi: 10.5306/wjco.122944
Revised: August 12, 2026
Accepted: October 10, 2026
Published online: November 24, 2026
Processing time: 199 Days and 0.1 Hours
Albumin and prealbumin are established prognostic factors for hepatocellular carcinoma (HCC), but their combined impact on post-resection long-term out
To compare the impact of albumin, prealbumin, and their combination on long-term postoperative outcomes in HCC patients.
The various impacts of albumin (low < 40 g/L, or normal ≥ 40 g/L) and prealbumin (low < 170 mg/L, or normal ≥ 170 mg/L) on overall survival (OS) and recurrence-free survival (RFS) for HCC patients following partial hepatectomy were comprehensively analyzed using a multi-institutional database.
During a median follow-up of 64.1 months, 892 recurrences and 675 deaths were recorded. Significant differences in OS and RFS were observed across the four groups (all P < 0.001). Compared with Group I (normal albumin and prealbumin), Group II (low albumin, normal prealbumin), Group III (normal albumin, low prealbumin), and Group IV (low albumin and low prealbumin) had shorter OS [Group II: hazard ratio (HR) = 1.37, 95%CI: 1.07-1.76; Group III: HR = 1.89, 95%CI: 1.49-2.39; Group IV: HR = 2.46, 95%CI: 2.02-2.99] and RFS (Group II: HR = 1.25, 95%CI: 1.02-1.54; Group III: HR = 1.65, 95%CI: 1.34-2.02; Group IV: HR = 1.95, 95%CI: 1.64-2.32). Multivariable analysis showed prealbumin was a dominant prognostic predictor for OS and RFS than albumin. When both markers were included, albumin lost independent prognostic value, while low prealbumin (regardless of albumin) remained an independent risk factor for worse OS and RFS. After adjusting for confounders, Group IV had the highest adjusted HR for reduced OS (1.65, 95%CI: 1.34-2.02, P < 0.001) and RFS (1.33, 95%CI: 1.10-1.60, P = 0.002). Time-dependent area under the curve analysis demonstrated that the combined stratification consistently outperformed albumin across all time points (all P < 0.001), with prealbumin showing modestly superior discrimination to albumin.
Prealbumin outperforms albumin as a prognostic biomarker for long-term survival after HCC resection. Comb
Core Tip: In this multicenter Chinese cohort of 1550 hepatocellular carcinoma patients undergoing curative resection, prealbumin demonstrated superior prognostic value over albumin for overall survival and recurrence-free survival. When both markers were combined, low prealbumin with normal or low albumin independently predicted worse outcomes, whereas isolated low albumin did not. This dual-marker approach enables precise risk stratification to guide surgical decisions and postoperative management.